Simulation of colorectal cancer screening: What we do and do not know and does it matter

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 4, 2010, Pages 427-437

  Van Ballegooijen, Marjolein ^a   Boer, Rob ^a   Zauber, Ann G ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colonoscopy; Colorectal neoplasms; Cost benefit analysis; Mass screening; Modelling; Occult blood; Sigmoidoscopy; Simulation

Indexed keywords

ADENOMA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; HIGH THROUGHPUT SCREENING; HUMAN; QUALITY OF LIFE; REVIEW; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; SIMULATION;

EID: 77956595132     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.07.001     Document Type: Article

References (29)

1. F. Loeve, M.L. Brown, R. Boer, M. van Ballegooijen, G.J. van Oortmarssen, and J.D. Habbema Endoscopic colorectal cancer screening: a cost-saving analysis J Natl Cancer Inst 92 7 Apr 5, 2000 557 563
2. M. Pignone, S. Saha, T. Hoerger, and J. Mandelblatt Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 137 2 Jul 16, 2002 96 104 (Pubitemid 34779153)
3. A.G. Zauber, I. Lansdorp-Vogelaar, A.B. Knudsen, J. Wilschut, M. van Ballegooijen, and K.M. Kuntz Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force Ann Intern Med 149 9 Nov 4, 2008 659 669
4. A.G. Zauber, A.B. Knudsen, C.M. Rutter, I. Lansdorp-Vogelaar, J.E. Savarino, and M. van Ballegooijen Cost-effectiveness of CT colonography to screen for colorectal cancer Available from: http://www1.cms.hhs.gov/mcd/ viewtechassess.asp?from2=viewtechassess.asp&where=index&tid=58& 2009
5. M. van Ballegooijen, J.D.F. Habbema, R. Boer, A.G. Zauber, and M.L. Brown Report to the Agency for Healthcare Research and Quality: a comparison of the cost-effectiveness of fecal occult blood tests with different test characteristics in the context of annual screening in the Medicare population Available from: http://www/cms.hhs.gov/coverage/download/id87.zip August 2003
6. Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Savarino JE, Van Ballegooijen M, Kuntz KM, et al. Cost-effectiveness of CT colonography screening for colorectal cancer in the Medicare population. J Natl Cancer Inst (in press).
7. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut JA, Zauber AG, Van Ballegooijen M. Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Int Med, (in press).
8. J. Mandel, J. Bond, T. Church, D.C. Snover, G.M. Bradley, and L.M. Schuman Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 19 May 13, 1993 1365 1371
9. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, and T.W. Balfour Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 9040 Nov 30, 1996 1472 1477
10. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 9040 Nov 30, 1996 1467 1471
11. W.S. Atkin, R. Edwards, I. Kralj-Hans, K. Wooldrage, A.R. Hart, and J.M. Northover Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 9726 May 8, 2010 1624 1633
12. D.K. Whynes, A.R. Neilson, A.R. Walker, and J.D. Hardcastle Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ 7 1 Feb 1998 21 29
13. D. Gyrd-Hansen, J. Sogaard, and O. Kronborg Colorectal cancer screening: efficiency and effectiveness Health Econ 7 1 Feb 1998 9 20 (Pubitemid 28112231)
14. G. Hoff, T. Grotmol, E. Skovlund, and M. Bretthauer Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial Br Med J 338 2009 b1846
15. L.J. Hixson, M.B. Fennerty, R.E. Sampliner, and H.S. Garewal Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps Gastrointest Endosc 37 2 Mar-Apr 1991 125 127
16. D.K. Rex, C.S. Cutler, G.T. Lemmel, E.Y. Rahmani, D.W. Clark, and D.J. Helper Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies Gastroenterology 112 1 Jan 1997 24 28
17. P.J. Pickhardt, J.R. Choi, I. Hwang, J.A. Butler, M.L. Puckett, and H.A. Hildebrandt Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults N Engl J Med 349 23 Dec 4, 2003 2191 2200
18. G. Castiglione, M. Zappa, G. Grazzini, A. Mazzotta, M. Biagini, and P. Salvadori Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer Br J Cancer 74 1 Jul 1996 141 144
19. L. Hol, J.A. Wilschut, M. van Ballegooijen, A.J. van Vuuren, H. van der Valk, and J.G. Reijerink Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 7 Apr 7, 2009 1103 1110
20. N. Segnan, C. Senore, B. Andreoni, H. Aste, L. Bonelli, and C. Crosta Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE J Natl Cancer Inst 94 23 Dec 4, 2002 1763 1772
21. J.K. Gohagan, P.C. Prorok, B.S. Kramer, R.B. Hayes, and J.E. Cornett The prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute Cancer 75 1995 1869 1873
22. N. Baxter, M. Goldwasser, L. Paszat, R. Saskin, D. Urbach, and L. Rabeneck A population-based case control study of the effectiveness of colonoscopy for prevention of death from CRC. Supplement to gastroenterology, digestive disease week 2007 Washington, DC
23. H. Brenner, M. Hoffmeister, V. Arndt, C. Stegmaier, L. Altenhofen, and U. Haug Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study J Natl Cancer Inst 102 2 Jan 20, 2010 89 95
24. M. Bretthauer The capsule and colorectal-cancer screening-the crux of the matter N Engl J Med 361 3 Jul 16, 2009 300 301
25. J. Brazier, J. Roberts, and M. Deverill The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 2 Mar 2002 271 292
26. I. Lansdorp-Vogelaar, M. van Ballegooijen, A.G. Zauber, J.D. Habbema, and E.J. Kuipers Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening J Natl Cancer Inst Sep 24, 2009
27. D. Schrag The price tag on progress-chemotherapy for colorectal cancer N Engl J Med 351 4 Jul 22, 2004 317 319
28. F. Loeve, R. Boer, A.G. Zauber, M. van Ballegooijen, G.J. van Oortmassen, and S.J. Winawer National Polyp Study data: evidence for regression of adenomas Int J Cancer 111 4 Sep 10, 2004 633 639
29. I. Lansdorp-Vogelaar, M. van Ballegooijen, R. Boer, A. Zauber, and J.D. Habbema A novel hypothesis on the sensitivity of the fecal occult blood test: results of a joint analysis of 3 randomized controlled trials Cancer 115 11 Jun 1, 2009 2410 2419